Literature DB >> 1564221

Dobutamine stress echocardiography for detection and assessment of coronary artery disease.

P K Mazeika1, A Nadazdin, C M Oakley.   

Abstract

Stress echocardiography with dobutamine infusion for detection of coronary artery disease is a potential alternative to exercise stress testing with some theoretic advantages. Fifty patients who were not receiving cardioactive medication were prospectively studied with two-dimensional echocardiography and 12-lead electrocardiography (ECG) during incremental dobutamine infusion (5, 10, 15 and 20 micrograms/kg body weight per min, each dose for 8 min). Images were analyzed by using an 11-segment left ventricular model. All patients underwent correlative exercise ECG and coronary angiography, which revealed normal coronary arteries in 14 and significant disease (greater than or equal to 70% diameter stenosis) in 36. Peak rate-pressure product during dobutamine infusion was 18,845 +/- 4,156 versus 23,740 +/- 6,158 mm Hg/min on exercise (p less than 0.01). Interobserver concordance for wall motion analysis was good (kappa coefficient = 0.77). The use of baseline (n = 14) or reversible (n = 24) regional asynergy to define an abnormal dobutamine echocardiogram resulted in a sensitivity for detecting coronary artery disease of 78% and a specificity of 93%. Corresponding data for the dobutamine ECG were 47% and 71% and for the exercise ECG were 72% and 71%, respectively. The development of new mitral regurgitation on Doppler color flow imaging (n = 4) improved sensitivity to 81% without loss of specificity. Inducible asynergy or new mitral regurgitation was observed in 6 (50%) of 12 patients with single-, 6 (60%) of 10 with double- and 12 (86%) of 14 with triple-vessel disease. The site of transient asynergy provided additional localizing information. Exercise duration and time to diagnostic ST segment shift were shorter in patients with coronary artery disease with versus those without echocardiographic evidence of ischemia (both p less than 0.05). Side effects during dobutamine infusion were mild and short-lived. Dobutamine stress echocardiography is well tolerated, is useful for detection and assessment of coronary artery disease and is applicable to patients unable to exercise.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1564221     DOI: 10.1016/0735-1097(92)90325-h

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

Review 1.  Pharmacologic stress testing: new methods and new agents.

Authors:  Robert C Hendel; Tariq Jamil; David K Glover
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

2.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

Review 3.  Update on new technologies in pediatric echocardiography.

Authors:  L I Bezold; M B Lewin; G W Vick; R Pignatelli
Journal:  Tex Heart Inst J       Date:  1997

Review 4.  The role of stress echocardiography versus stress perfusion: a view from the other side.

Authors:  F A Chaudhry
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

Review 5.  Stress echocardiography: methods, indications and results.

Authors:  L H B Baur
Journal:  Neth Heart J       Date:  2002-03       Impact factor: 2.380

6.  Safety and efficacy of physiologist-led dobutamine stress echocardiography: experience from a tertiary cardiac centre.

Authors:  Theodoros Ntoskas; Farhanda Ahmad; Paul Woodmansey
Journal:  Echo Res Pract       Date:  2018-07-04

7.  Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and echocardiography for optimal detection of multivessel coronary artery disease.

Authors:  R S Khattar; R Senior; A Lahiri
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

8.  A comparison of dobutamine and maximal exercise as stress for thallium scintigraphy.

Authors:  D R Wallbridge; A C Tweddel; W Martin; I Hutton
Journal:  Eur J Nucl Med       Date:  1993-04

9.  Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis.

Authors:  David R Altmann; Wolfgang Korte; Micha T Maeder; Thomas Fehr; Philipp Haager; Hans Rickli; Gian-Reto Kleger; Regulo Rodriguez; Peter Ammann
Journal:  PLoS One       Date:  2010-02-03       Impact factor: 3.240

10.  Dobutamine 99mTc-MIBI single-photon emission tomography: non-exercise-dependent detection of haemodynamically significant coronary artery stenoses.

Authors:  E Voth; F M Baer; P Theissen; C A Schneider; U Sechtem; H Schicha
Journal:  Eur J Nucl Med       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.